Skip to main content

stock

APUS · Apimeds Pharmaceuticals US, Inc.

What Apimeds Pharmaceuticals US, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live APUS price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on APUS.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
1,509,118 as of 2026-08-12 (XBRL frame )

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
-54.6%
ROA
-45.6%

Health

Current ratio
0.5x
Debt/equity
—

Deep value

NCAV
-$10.50M
NCAV per share
-$6.96
Price/NCAV
Locked
NNWC
-$20.90M
NNWC per share
-$13.85
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenue (not reported by this company)Gross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$6.28M-$20.17M
10-Q filed 2026-08-14
2026-03-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$12.19M-$35.06M
10-Q filed 2026-08-14
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$7.04M-$1.16M
10-K filed 2026-05-04
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$1.84M-$1.78M
10-Q filed 2025-11-12
2025-06-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$2.66M-$2.66M
10-Q filed 2026-08-14
2025-03-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$364,368-$402,397
10-Q filed 2026-08-14
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$275,613-$311,633
10-K filed 2026-05-04
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$299,999-$332,521
10-Q filed 2025-11-12
Assets
$127.62M
Equity
$106.45M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31—-$11.91M-$6.00M-$8.98M
2024-12-31—-$1.28M-$1.39M—
2023-12-31—-$747,436-$777,694—

Company filings

events

  • Executive or director change

    Executive or director change
    Oct 18-K
  • Other event

    Other event
    Sep 298-K
  • Shareholder rights changed, Bylaws or fiscal year change

    Shareholder rights changedBylaws or fiscal year change
    Sep 228-K
  • Material agreement, Executive or director change

    Material agreementExecutive or director change
    Sep 118-K
  • Material agreement

    Material agreement
    Aug 218-K
  • Other event

    Other event
    Aug 68-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named APUS, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about APUS.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about APUS.

nakagai

Signals on APUS come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the APUS board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.